Advertisement

FDA OKs marketing Plan B to 17-year-olds

Share

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts.

The Food and Drug administration announced today that it has notified the maker of Plan B, the morning-after pill, permitting it to market the drug to 17-year-olds without a prescription. The move follows a March ruling by a federal judge that the FDA’s earlier decision requiring those younger than 18 to consult with a doctor was not justified on safety grounds.

Here’s a recent article on the Plan B issue. And here’s more info plus what others are saying about this latest move:

Advertisement

The FDA statement and a page detailing the drug’s regulatory history;

Center for Reproductive Rights, which sued the FDA on its delay to grant over-the-counter access of Plan B;

Family Research Council, which opposes the judge’s ruling;

An Associated Press article on the FDA’s latest move;

Plan B website.

-- Rosie Mestel

Advertisement